FDA Approval For CEL-SCI’s Multikine Confirmatory Study in Head and Neck Cancer
CEL-SCI's Multikine represents a major leap forward in oncological care, now moving into a crucial phase ...
Read moreCEL-SCI's Multikine represents a major leap forward in oncological care, now moving into a crucial phase ...
Read moreGlobal Market Bulletin TV recently conducted an exclusive interview with Geert Kersten, the CEO of CEL-SCI ...
Read moreIn this episode of Global Market Bulletin TV, host Leyla Gulen interviews CEL-SCI Corporation CEO Geert ...
Read moreGlobal Market Bulletin is a leading provider of financial news & economic info for investors including stock market updates, analyst investing reports and executive video interviews.
© 2022 Global Market Bulletin. All Rights Reserved.